Results 191 to 200 of about 123,621 (353)

A call for action: Closing the evidence gap in management of stimulant‐induced psychosis

Addiction, EarlyView.
Abstract Background Stimulant‐induced psychosis (StIP) is emerging as one of most pressing health challenges. Over the past two decades, stimulant‐related harms and psychiatric care demands have risen sharply. Individuals with StIP often present with severe agitation and high suicide risk, and up to half progress to chronic psychotic illness within two
Anne Bouthillier, Heidar Sharafi, Adam Bisaga, Didier Jutras‐Aswad   +3 more
wiley   +1 more source

High temporal resolution monitoring of illicit drug consumption across England via wastewater analysis

Addiction, EarlyView.
Abstract Aim To monitor community‐level consumption of 20 illicit drugs across urban areas of England using wastewater‐based epidemiology (WBE) surveillance at high temporal resolution. Design, setting, cases This study was conducted over a 12‐month period in 2022 sampling 24‐hour composite wastewater samples at 15 wastewater treatment plants (WWTPs ...
Helena Rapp‐Wright, Keng Tiong Ng, Derryn Grant, William Francis, Margarita White, Dimitris Evangelopoulos, Yuxing Liu, Konstantina Dimakopoulou, Sofia Zafeiratou, Dylan Wood, Chryshanthi Christy, Stav Friedman, Timothy W. Gant, Klea Katsouyanni, Leon P. Barron   +14 more
wiley   +1 more source

Investigating medical cannabis for adolescents with Tourette syndrome: tread carefully. [PDF]

BJPsych Open
Abi-Jaoude E.
europepmc   +1 more source

Comparative effectiveness, safety and acceptability of pharmacological and psychosocial interventions for the treatment of cannabis use disorder: A network meta‐analysis

Addiction, EarlyView.
Abstract Aim Our primary aim was to conduct a network meta‐analysis (NMA) for the effectiveness, safety and acceptability of all psychosocial interventions and all pharmacotherapies for cannabis use disorder (CUD). Methods We conducted a NMA of studies identified from two completed systematic reviews examining the effectiveness, safety and ...
Monika Halicka, Francesca Spiga, Tom P. Freeman, Suzanne Nielsen, Jelena Savović, Julian P. T. Higgins, Deborah M. Caldwell   +6 more
wiley   +1 more source

Medical cannabis utilization in children - a study based on a nationwide cohort. [PDF]

Front Pharmacol
Treves N, Yakirevich-Amir N, Allegaert K, van den Anker JN, Kohn E, Berlin M, Hazan A, Davidson E, Berkovitch M, Bonne O, Stolar OE, Matok I.   +11 more
europepmc   +1 more source

Associations between medical cannabis and prescription opioid use in chronic pain patients: A preliminary cohort study

, 2017
Jacob M. Vigil, Sarah S. Stith, Ian M. Adams, Anthony P. Reeve   +3 more
openalex   +2 more sources

The association between sleep disturbance and stimulant use: A cross‐lagged examination

Addiction, EarlyView.
Abstract Background and aims Sleep disruptions increase the risk of substance misuse. Substance use—especially stimulants—can increase acute and chronic sleep dysfunction. This study aimed to estimate the associations between sleep disturbance and stimulant use over time among participants with stimulant use disorder (StUD).
Viviana E. Horigian, Renae D. Schmidt, Daniel J. Feaster, Rui Duan, Sophia T. Gonzalez, Kathryn Hefner, Dikla Shmueli‐Blumberg, Ashley Vena, Landhing M. Moran, Chloe A. DiCamillo, Shirin Shafazand, Susan Tross, Judith Feinberg   +12 more
wiley   +1 more source

Changes in sleep quality during the 12 months following medical cannabis initiation. [PDF]

J Cannabis Res
Short MM, Lent MR, McCalmont TR, Dugosh KL.   +3 more
europepmc   +1 more source

Attitudes and experiences about medical cannabis in palliative care patients and caregivers in Thailand: a qualitative study

Khanet Khamjae, Win Techakehakij, Wararat Thatayu, Napat Phetkub, Nutchar Subhamani   +4 more
openalex   +2 more sources

Medical cannabis in Israel: a comprehensive review of trends and regulations, 2011-2025. [PDF]

J Cannabis Res
Aviram J.
europepmc   +1 more source